News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 228 results

English court issues mixed ruling in heart valve patent clash

India, UK30-09-2020Sarah Morgan

The English High Court has handed down a mixed ruling in a dispute between Edwards Lifesciences and its competitor Meril Life Sciences.

Bausch Health settles with Sun Pharma

Canada, India, US23-09-2020Sarah Morgan

Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

Indian police seize black market remdesivir, arrest 14

India21-07-2020Rory O'Neill

Police in Mumbai and Hyderabad have arrested 14 people on suspicion of distributing black market remdesivir at five times its retail price.

Rouse and Codex launch new China partnership

China04-06-2020

IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.

WHO launches COVID-19 pool with 37 countries

International29-05-2020Sarah Morgan

The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative. 

Personal Genomics takes PacBio dispute to Chinese court

China22-05-2020Rory O'Neill

Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.

WHO and Costa Rica to launch COVID-19 technology patent pool

International19-05-2020Sarah Morgan

The World Health Organization and Costa Rica will launch a technology pooling initiative to help fight the COVID-19 pandemic.

US companies hit hardest by fake medicines: EUIPO, OECD

EU24-03-2020Sarah Morgan

Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office. 

India restricts drug exports, fueling shortage fears

India04-03-2020Rory O'Neill

India has imposed export restrictions on drugs and active pharmaceutical ingredients (APIs), including paracetamol, amid fears over COVID-19-related shortages.

Vir Biotech partners with WuXi on COVID-19 antibody treatment

China, Hong Kong, US27-02-2020Sarah Morgan

Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.

Showing 1 to 10 of 228 results

LSIPR